Effects of rabeprazole on acute exacerbation in chronic obstructive pulmonary disease (COPD) patients with acid reflux symptoms
Not Applicable
Recruiting
- Conditions
- chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease
- Registration Number
- JPRN-UMIN000002056
- Lead Sponsor
- Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients treated with gastric secretion inhibitor in a month prior to this study. 2.Patients with active peptic ulcer or Zollinger-Ellison syndrome. 3.Patients with malignancy. 4.Patients with cardiac, hepatic or hematologic disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of acute exacerbation of chronic obstructive pulmonary disease in a year
- Secondary Outcome Measures
Name Time Method Frequency of common cold in a year